Literature DB >> 33628829

miR-193a-3p Promotes the Invasion, Migration, and Mesenchymal Transition in Glioma through Regulating BTRC.

Dan-Dan Zhou1, Hong-Li Li1,2, Wei Liu3, Li-Ping Zhang1, Quan Zheng1, Jun Bai1, Ya-Qiong Hu1, Chong-Gao Yin4, Shi-Jun Lv1, Bao-Gang Zhang1.   

Abstract

BACKGROUND: The present study is aimed at exploring the specific expression of miR-193a-3p and the mechanism underlying miR-193a-3p-mediated mesenchymal transition (MT), invasion, and migration in glioma.
METHODS: The gene expression profile datasets of GSE39486 and GSE25676 were downloaded from the National Center for Biotechnology (NCBI). Data regarding the expression of miR-193a-3p and survival curves were derived from Chinese Glioma Genome Atlas (CGGA). Online websites including miRWalk, DIANA, and starbase were employed to predict the target genes for miR-193a-3p. The Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed by the Omicsbean online software. Module analysis of the protein-protein interaction (PPI) networks was performed by the plug-in Molecular Complex Detection (MCODE), and the degrees of genes were calculated by CytoHubba plug-in of Cytoscape. Survival curves were based on the Gene Expression Profile Interaction Analysis (GEPIA). Transwell, wound healing, and Western blot experiments were performed to investigate the effects of miR-193a-3p and beta-transducin repeat containing E3 ubiquitin protein ligase (BTRC) on the invasion, migration, and MT of glioma.
RESULTS: miR-193a-3p was highly expressed in glioma tissues and significantly correlated with poor survival in patients with glioma. The target genes for miR-193a-3p were involved in many cancer-related signaling pathways. The PPI showed 11 genes with both high degrees and MCODE scores in the network. Survival analysis demonstrated that the expression of BTRC was significantly correlated with the prognosis of patients with glioma. The results from the transwell, wound healing, and Western blot analyses suggested that miR-193a-3p promoted the invasion, migration, and MT of glioma cells, which could be reversed by BTRC.
CONCLUSIONS: miR-193a-3p was upregulated in patients with glioma and could affect the invasion, migration, and MT of glioma by regulating BTRC.
Copyright © 2021 Dan-Dan Zhou et al.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33628829      PMCID: PMC7886567          DOI: 10.1155/2021/8928509

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


  50 in total

1.  miR-429 inhibits glioma invasion through BMK1 suppression.

Authors:  Weiyi Chen; Baogang Zhang; Wenjun Guo; Linlin Gao; Lihong Shi; Hongli Li; Shijun Lu; Yuqing Liu; Xiaolong Li
Journal:  J Neurooncol       Date:  2015-08-14       Impact factor: 4.130

Review 2.  Roles of microRNAs during glioma tumorigenesis and progression.

Authors:  Shuwei Wang; Yutong Yin; Shuang Liu
Journal:  Histol Histopathol       Date:  2018-09-14       Impact factor: 2.303

3.  Degradation of the transcription factor Twist, an oncoprotein that promotes cancer metastasis.

Authors:  Jiateng Zhong; Kohei Ogura; Zhiwei Wang; Hiroyuki Inuzuka
Journal:  Discov Med       Date:  2013-01       Impact factor: 2.970

4.  Clinical and biological significance of miR-193a-3p targeted KRAS in colorectal cancer pathogenesis.

Authors:  Afraa Mamoori; Riajul Wahab; Farhadul Islam; Katherine Lee; Jelena Vider; Cu-Tai Lu; Vinod Gopalan; Alfred King-Yin Lam
Journal:  Hum Pathol       Date:  2017-11-02       Impact factor: 3.466

5.  STRING v10: protein-protein interaction networks, integrated over the tree of life.

Authors:  Damian Szklarczyk; Andrea Franceschini; Stefan Wyder; Kristoffer Forslund; Davide Heller; Jaime Huerta-Cepas; Milan Simonovic; Alexander Roth; Alberto Santos; Kalliopi P Tsafou; Michael Kuhn; Peer Bork; Lars J Jensen; Christian von Mering
Journal:  Nucleic Acids Res       Date:  2014-10-28       Impact factor: 16.971

6.  GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.

Authors:  Zefang Tang; Chenwei Li; Boxi Kang; Ge Gao; Cheng Li; Zemin Zhang
Journal:  Nucleic Acids Res       Date:  2017-07-03       Impact factor: 16.971

Review 7.  MicroRNAs as potential biomarkers for the diagnosis of glioma: A systematic review and meta-analysis.

Authors:  Qian Zhou; Jing Liu; Jing Quan; Wenlan Liu; Hui Tan; Weiping Li
Journal:  Cancer Sci       Date:  2018-08-03       Impact factor: 6.716

8.  Development of novel predictive miRNA/target gene pathways for colorectal cancer distance metastasis to the liver using a bioinformatic approach.

Authors:  Precious Takondwa Makondi; Po-Li Wei; Chien-Yu Huang; Yu-Jia Chang
Journal:  PLoS One       Date:  2019-02-26       Impact factor: 3.240

9.  The role of miR-382-5p in glioma cell proliferation, migration and invasion.

Authors:  Jinjin Wang; Chunfeng Chen; Xu Yan; Peng Wang
Journal:  Onco Targets Ther       Date:  2019-06-25       Impact factor: 4.147

10.  Upregulated microRNA-193a-3p is responsible for cisplatin resistance in CD44(+) gastric cancer cells.

Authors:  So D Lee; Dayeon Yu; Do Y Lee; Hyun-Soo Shin; Jeong-Hyeon Jo; Yong C Lee
Journal:  Cancer Sci       Date:  2018-12-26       Impact factor: 6.716

View more
  7 in total

1.  [MiR-671-5p negatively regulates SMAD3 to inhibit migration and invasion of osteosarcoma cells].

Authors:  Y Hu; D Liang; X Chen; L Chen; J Bai; H Li; C Yin; W Zhong
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-10-20

2.  MiR-379-5p inhibits the proliferation, migration, and invasion of breast cancer by targeting KIF4A.

Authors:  Ke Yang; Danyang Li; Weihui Jia; Yanmei Song; Ningxin Sun; Jiemin Wang; Hongli Li; Chonggao Yin
Journal:  Thorac Cancer       Date:  2022-05-24       Impact factor: 3.223

3.  Circ_0003340 downregulation mitigates esophageal squamous cell carcinoma progression by targeting miR-940/PRKAA1 axis.

Authors:  Xingzhuo Guan; Xiaohui Guan; Yuanshi Wang; Tingzhu Lan; Tongshuang Cheng; Yan Cui; Hongjun Xu
Journal:  Thorac Cancer       Date:  2022-03-17       Impact factor: 3.223

4.  Prognostic values of the core components of the mammalian circadian clock in prostate cancer.

Authors:  Wenchang Yue; Xiao Du; Xuhong Wang; Niu Gui; Weijie Zhang; Jiale Sun; Jiawei You; Dong He; Xinyu Geng; Yuhua Huang; Jianquan Hou
Journal:  PeerJ       Date:  2021-12-09       Impact factor: 2.984

5.  Establishment of Sunitinib-Resistant Xenograft Model of Renal Cell Carcinoma and the Identification of Drug-Resistant Hub Genes and Pathways.

Authors:  Yingwei Xie; Wentai Shangguan; Zhiliang Chen; Zaosong Zheng; Yuqing Chen; Qiyu Zhong; Yishan Zhang; Jingying Yang; Dingjun Zhu; Wenlian Xie
Journal:  Drug Des Devel Ther       Date:  2021-12-16       Impact factor: 4.162

6.  Complement C7 is Specifically Expressed in Mesangial Cells and is a Potential Diagnostic Biomarker for Diabetic Nephropathy and is Regulated by miR-494-3p and miR-574-5p.

Authors:  Hang Guo; Zhiyue Yan; Yonghui Hu; Xitong Huang; Congqing Pan
Journal:  Diabetes Metab Syndr Obes       Date:  2021-07-05       Impact factor: 3.168

7.  miR-193a Directly Targets PSEN1 and Inhibits Gastric Cancer Cell Growth, the Activation of PI3K/Akt Signaling Pathway, and the Epithelial-to-Mesenchymal Transition.

Authors:  Xuemei Pan; Ting Zhao; Saisai Mu; Shouchuan Li
Journal:  J Oncol       Date:  2021-07-14       Impact factor: 4.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.